Explore more publications!

The German Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The German Herald.

Press releases published on October 16, 2025

NGMEDICAL WILL PRESENT ITS UNIQUE PRODUCT PORTFOLIO AT EUROSPINE
Canadian Musician Dave Sereny Unveils 'Brighter Days' for World  Positivity Month
NovaCentrix Introduces Metalon® HPSC-U Family of Silver-Coated Copper Inks: High Performance at a Fraction of the Cost
Legendary ‘Infinity’ On Game Boy Color Finally Comes To Fruition 23 Years after its cancellation
Newsmatics Highlights AI’s Role in News Distribution at Mid-Atlantic MarCom Summit
KENTEX Launches Lycoris Recoil Collaboration Watch  – Limited to 300 Pieces Worldwide
Driver Monitoring Systems Market to Reach $4.6 Billion by 2031, Driven by Vehicle Safety Demand
The Art of the Future — Balfour Capital Group Launches Tokenized Artwork Collection with Sabatier Art
Autofleet Named “Fleet Management Solution of the Year” By AutoTech Breakthrough Annual Awards Program
MaintMaster übernimmt Peoplegeist – KI gestützte Effizienzsteigerung für Instandhaltung und Produktion
LuggageToShip.com Expands ‘Travel and Pay’ Platform to Simplify Global Travel
Over 56% of Companies Manage Social Media In-House, According to TechBehemoths
atai Life Sciences Announces Proposed Public Offering of Common Shares
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
Pharmaceutical Capsule Filling Machines Market in Germany to Grow at 4.2% CAGR Through 2035
Tilde enters the global AI race with a European multilingual model and safeguards against disinformation
GPT Proto Now Offers Google's Veo 3.1 AI Video Generation
Furuno to exhibit at the International Timing and Sync Forum (ITSF) 2025
Turning Miles Into Memories: GetYourGuide Joins the 2025 TCS New York City Marathon as Official Travel Experiences Partner
Aicuris Announces Pritelivir Met Primary Endpoint in Immunocompromised Patients with Refractory Herpes Simplex Virus in Phase 3 Pivotal Trial

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions